Nicholas R. Thomas-Medjeral
Stevenage, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy.
Journal: Pediatric nephrology (Berlin, Germany)
Published: May 13, 2025
Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes.
Journal: Kidney international reports
Published: November 10, 2024
Temporal multi-omics analysis of COVID-19 in end-stage kidney disease.
Journal: Cell genomics
Published: June 28, 2024
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Journal: Kidney international reports
Published: July 14, 2023
Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?
Journal: Kidney international reports
Published: May 16, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: December 29, 2021
Complement activation in IgA nephropathy.
Journal: Seminars in immunopathology
Published: July 02, 2021
New Insights into Epidemiology and Outcome of Bacterial Infection-Related Glomerulonephritis.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: June 08, 2021
Protease inhibitor plasma concentrations associate with COVID-19 infection.
Journal: Oxford open immunology
Published: April 23, 2021
Complement and kidney disease, new insights.
Journal: Current opinion in nephrology and hypertension
Published: March 26, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease.
Journal: Frontiers in immunology
Published: February 22, 2021
Last Updated: 09/26/2026